Pfizer used technologies developed by another company in its COVID-19 vaccine, infringing on patents, according to a new lawsuit.
The Pfizer–BioNTech COVID-19 messenger RNA (mRNA) vaccine uses lipid nanoparticle (LNP) technology that was developed and patented by Arbutus Biopharma, Arbutus alleges in the suit, filed on April 4 in the U.S. District Court for the District of New Jersey.
